RT Journal Article
SR Electronic
T1 Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 63
DO 10.1186/s40425-019-0547-7
VO 7
IS 1
A1 Kellie N. Smith
A1 Nicolas J. Llosa
A1 Tricia R. Cottrell
A1 Nicholas Siegel
A1 Hongni Fan
A1 Prerna Suri
A1 Hok Yee Chan
A1 Haidan Guo
A1 Teniola Oke
A1 Anas H. Awan
A1 Franco Verde
A1 Ludmila Danilova
A1 Valsamo Anagnostou
A1 Ada J. Tam
A1 Brandon S. Luber
A1 Bjarne R. Bartlett
A1 Laveet K. Aulakh
A1 John-William Sidhom
A1 Qingfeng Zhu
A1 Cynthia L. Sears
A1 Leslie Cope
A1 William H. Sharfman
A1 Elizabeth D. Thompson
A1 Joanne Riemer
A1 Kristen A. Marrone
A1 Jarushka Naidoo
A1 Victor E. Velculescu
A1 Patrick M. Forde
A1 Bert Vogelstein
A1 Kenneth W. Kinzler
A1 Nickolas Papadopoulos
A1 Jennifer N. Durham
A1 Hao Wang
A1 Dung T. Le
A1 Sune Justesen
A1 Janis M. Taube
A1 Luis A. Diaz Jr
A1 Julie R. Brahmer
A1 Drew M. Pardoll
A1 Robert A. Anders
A1 Franck Housseau
YR 2019
UL http://jitc.bmj.com/content/7/1/63.abstract
AB .Kellie N. Smith and Nicolas J. Llosa contributed equally to this work.The original article can be found online at 10.1186/s40425-018-0492-x